On September 26, 2017 Jeffery Bacha, CEO of DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) interviews on the Uptick Network Stock Day Podcast with host Everett Jolly. Mr. Bacha discusses DelMar’s VOL-083 phase 3 clinical trial chemotherapy that has recently launched and how this trial has progressed since its launch (Press release, DelMar Pharmaceuticals, SEP 26, 2017, View Source [SID1234520651]). Delmar recently completed a financing, and Mr. Bacha explains how this financing benefits the company and supports DelMar’s clinical trials. Furthermore, Mr. Bacha discusses the major milestones for the future of DelMar and what the company is looking to accomplish with its research and clinical trials.

In closing, CEO Jeffery Bacha states, “There is a wonderful story about a fellow who is a glioblastoma patient and he was treated the Monday, Tuesday and Wednesday prior to the weekend that he and his wife joined us on what’s called The Ride to Concur Cancer. He rode over 250 kilometers from Vancouver British Columbia to Seattle and he’s on our drug and he’s tolerating it very well,” Mr. Bacha continues, “It is amazing to be a part of that with him. Just knowing that this is someone that we are hopefully going to be able to help and being a part of that puts this into perspective of how important this is and we are looking to do that for many more patients.”

To listen to the full interview please click here or the following link: View Source